AstraZeneca

Type
Business expansion
Country
Poland
Region
Makroregion województwo mazowieckie; Warszawski stołeczny; Miasto Warszawa
Location of affected unit(s)
Warsaw
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations
250 jobs
Number of planned job creations
Job creation
Announcement Date
7 November 2018
Employment effect (start)
7 November 2018
Foreseen end date
6 November 2019

Description

The Anglo-Swedish pharmaceutical and biopharmaceutical company AstraZeneca has announced plans to create 250 new positions at its units in Warsaw. AstraZeneca is mainly looking for IT and statistics specialists. Most of the new employees will work in the research and development centre, which focuses on research and medicine testing. The company has also revealed that more than PLN 1.5 billion (€349.6 million) will be invested by the end of 2022 in the Polish market. As of November 2018, AstraZeneca operates across 100 countries and employs around 51,700 staff globally.

Citation

Eurofound (2018), AstraZeneca, Business expansion in Poland, factsheet number 95934, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/95934.